Literature DB >> 27198800

Vertical transmission and fetal damage in animal models of congenital toxoplasmosis: A systematic review.

José Antonio Vargas-Villavicencio1, Alejandro Besné-Mérida1, Dolores Correa2.   

Abstract

In humans, the probability of congenital infection and fetal damage due to Toxoplasma gondii is dependent on the gestation period at which primary infection occurs. Many animal models have been used for vaccine, drug testing, or studies on host or parasite factors that affect transmission or fetal pathology, but few works have directly tested fetal infection and damage rates along gestation. So, the purpose of this work was to perform a systematic review of the literature to determine if there is a model which reflects these changes as they occur in humans. We looked for papers appearing between 1970 and 2014 in major databases like Medline and Scopus, as well as gray literature. From almost 11,000 citations obtained, only 49 papers fulfilled the criteria of having data of all independent variables and at least one dependent datum for control (untreated) groups. Some interesting findings could be extracted. For example, pigs seem resistant and sheep susceptible to congenital infection. Also, oocysts cause more congenitally infected offspring than tissue cysts, bradyzoites or tachyzoites. In spite of these interesting findings, very few results on vertical transmission or fetal damage rates were similar to those described for humans and only for one of the gestation thirds, not all. Moreover, in most designs tissue cysts - with unknown number of bradyzoites - were used, so actual dose could not be established. The meta-analysis could not be performed, mainly because of great heterogeneity in experimental conditions. Nevertheless, results gathered suggest that a model could be designed to represent the increase in vertical transmission and decrease in fetal damage found in humans under natural conditions.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal model; Congenital toxoplasmosis; Systematic review; Toxoplasma gondii

Mesh:

Year:  2016        PMID: 27198800     DOI: 10.1016/j.vetpar.2016.04.024

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  6 in total

1.  Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis.

Authors:  Joachim Müller; Adriana Aguado-Martínez; Luis-Miguel Ortega-Mora; Javier Moreno-Gonzalo; Ignacio Ferre; Matthew A Hulverson; Ryan Choi; Molly C McCloskey; Lynn K Barrett; Dustin J Maly; Kayode K Ojo; Wes Van Voorhis; Andrew Hemphill
Journal:  J Antimicrob Chemother       Date:  2017-08-01       Impact factor: 5.790

Review 2.  Potential Sabotage of Host Cell Physiology by Apicomplexan Parasites for Their Survival Benefits.

Authors:  Shalini Chakraborty; Sonti Roy; Hiral Uday Mistry; Shweta Murthy; Neena George; Vasundhra Bhandari; Paresh Sharma
Journal:  Front Immunol       Date:  2017-10-13       Impact factor: 7.561

3.  Evidence of high exposure to Toxoplasma gondii in free-ranging and captive African carnivores.

Authors:  Susana Carolina Martins Ferreira; Francesca Torelli; Sandra Klein; Robert Fyumagwa; William B Karesh; Heribert Hofer; Frank Seeber; Marion L East
Journal:  Int J Parasitol Parasites Wildl       Date:  2018-12-24       Impact factor: 2.674

4.  Cyclooxygenase (COX)-2 modulates Toxoplasma gondii infection, immune response and lipid droplets formation in human trophoblast cells and villous explants.

Authors:  Guilherme de Souza; Rafaela José Silva; Iliana Claudia Balga Milián; Alessandra Monteiro Rosini; Thádia Evelyn de Araújo; Samuel Cota Teixeira; Mário Cézar Oliveira; Priscila Silva Franco; Claudio Vieira da Silva; José Roberto Mineo; Neide Maria Silva; Eloisa Amália Vieira Ferro; Bellisa Freitas Barbosa
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

5.  Virulence in Mice of a Toxoplasma gondii Type II Isolate Does Not Correlate With the Outcome of Experimental Infection in Pregnant Sheep.

Authors:  Roberto Sánchez-Sánchez; Ignacio Ferre; Javier Regidor-Cerrillo; Daniel Gutiérrez-Expósito; Luis Miguel Ferrer; Noive Arteche-Villasol; Javier Moreno-Gonzalo; Joachim Müller; Adriana Aguado-Martínez; Valentín Pérez; Andrew Hemphill; Luis Miguel Ortega-Mora; Julio Benavides
Journal:  Front Cell Infect Microbiol       Date:  2019-01-04       Impact factor: 5.293

6.  Establishment and validation of a guinea pig model for human congenital toxoplasmosis.

Authors:  Thomas Grochow; Britta Beck; Zaida Rentería-Solís; Gereon Schares; Pavlo Maksimov; Christina Strube; Johannes Seeger; Lisa Raqué; Reiner Ulrich; Arwid Daugschies; Simone A Fietz
Journal:  Parasit Vectors       Date:  2021-08-06       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.